Aurora Cannabis (NASDAQ:ACB) reported quarterly earnings results on February 04, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.02, missing the consensus estimate of $0.19 by $0.17 per share. Revenue came in at $67.6M, beating the estimate of $65.9M.
Aurora Cannabis's stock moved following the earnings release. The stock currently trades at $3.31 with a market capitalization of $257.1M.